Telix Pharmaceuticals Limited American Depositary Receipt (TLX)

Delisted

5 Aug 2026

NASDAQ (NGS)

$

10. 42

+0.13

+1.2634%

3.41B Market Cap

- P/E Ratio

- Div Yield

99,035 Volume

- Eps

$ 10.29

Previous Close

Investors:

Day Range

10.41 10.48

Year Range

6.28 12.6

Want to track TLX and more in your Portfolio? 🎯

Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Get Started For Free

Telix Pharmaceuticals Limited American Depositary Receipt Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
YA Yinka Akinsola Blue Trust Inc.	742	$5,557.58	$7,338.38	$1,780.8	32.04%
PF Phillip Fitzsimmons Hennion & Walsh Asset Management Inc.	150,138	$1.43M	$1.48M	$52,548.3	3.67%
Brian Baylis Bell Investment Advisors Inc.	70	$669.9	$669.9	-	-
KMT Kirk M. Tokheim Ameritas Advisory Services LLC	90	$1.04	$1.04	-	-
Parth Karia Capricorn Fund Managers Ltd.	36,100	$344,394	$357,029	$12,635	3.67%
Arpan Shah XY Capital Ltd.	71,291	$797,383.48	$821,985	$24,601.52	3.09%
Hui Fai Tam Caitong International Asset Management Co. Ltd.	11	$127	$108.79	-$18.21	-14.34%
John Shanley Aspect Partners, LLC	401	$3,104.33	$3,965.89	$861.56	27.75%
Christopher C. Powers Farther Finance Advisors, LLC	14	$133.7	$138.46	$4.76	3.56%
SAM Smartleaf Asset Management LLC Smartleaf Asset Management LLC	37	$286.75	$354.09	$67.34	23.48%
Pascal Bechtold Raiffeisen Bank International AG	130,000	$1.24M	$1.29M	$41,600	3.34%
SummitTX Capital LP SummitTX Capital LP	31,621	$364,590	$364,590	-	-

1

Blog Affiliate Program About Terms Privacy Help Contact Us

2026 © Marketlog. All Rights Reserved.